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Background: Retinal microvascular alterations have been previously described in
Parkinson’s disease (PD) patients using optical coherence tomography angiography
(OCT-A). However, an extensive description of retinal vascular morphological features,
their association with PD-related clinical variables and their potential use as diagnostic
biomarkers has not been explored.
Methods: We performed a cross-sectional study including 49 PD patients (87 eyes) and
40 controls (73 eyes). Retinal microvasculature was evaluated with Spectralis OCT-A
and cognitive status with Montreal Cognitive Assessment. Unified PD Rating Scale and
disease duration were recorded in patients. We extracted microvascular parameters
from superficial and deep vascular plexuses of the macula, including the area and
circularity of foveal avascular zone (FAZ), skeleton density, perfusion density, vessel
perimeter index, vessel mean diameter, fractal dimension (FD) and lacunarity using
Python and MATLAB. We compared the microvascular parameters between groups
and explored their association with thickness of macular layers and clinical outcomes.
Data were analyzed with General Estimating Equations (GEE) and adjusted for age, sex,
and hypertension. Logistic regression GEE models were fitted to predict diagnosis of PD
versus controls from microvascular, demographic, and clinical data. The discrimination
ability of models was tested with receiver operating characteristic curves.
Results: FAZ area was significantly smaller in patients compared to controls in
superficial and deep plexuses, whereas perfusion density, skeleton density, FD and
lacunarity of capillaries were increased in the foveal zone of PD. In the parafovea,
microvascular parameters of superficial plexus were associated with ganglion cell-
inner plexiform layer thickness, but this was mainly driven by PD with mild cognitive
impairment. No such associations were observed in controls. FAZ area was negatively
associated with cognition in PD (non-adjusted models). Foveal lacunarity, combined
with demographic and clinical confounding factors, yielded an outstanding diagnostic
accuracy for discriminating PD patients from controls.
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Conclusion: Parkinson’s disease patients displayed foveal microvascular alterations
causing an enlargement of the vascular bed surrounding FAZ. Parafoveal microvascular
alterations were less pronounced but were related to inner retinal layer thinning. Retinal
microvascular abnormalities helped discriminating PD from controls. All this supports
OCT-A as a potential non-invasive biomarker to reveal vascular pathophysiology and
improve diagnostic accuracy in PD.
Keywords: neurodegeneration, angiography, capillary, density, Parkinson’s disease, retina, optical coherence
tomography, biomarker
INTRODUCTION
Parkinson’s disease (PD) is a progressive neurodegenerative
disease characterized by motor impairment, including rest
tremor, muscle rigidity, bradykinesia, and postural imbalance.
The main hallmark of PD is the accumulation of anomalous
α-synuclein deposits within neuronal cytoplasm, presumably
resulting in profound loss of neurons, mainly of dopaminergic
neurons (Lotharius and Brundin, 2002). The pathological
features of PD have also been observed in postmortem retinas
(Ortuno-Lizaran et al., 2018), and several in vivo cross-sectional
studies have reported reduced retinal thickness in PD by
means of optical coherence tomography (OCT) (Chrysou et al.,
2019). Retinal atrophy seems to be specific to the inner retinal
layers, concretely, to macular ganglion cell-inner plexiform
complex (GCIPL) around the fovea (Murueta-Goyena et al.,
2019), where the largest amount of retinal dopaminergic cells
is found (Ortuño-Lizarán et al., 2020). The GCIPL thinning
is significantly more pronounced in PD patients over time
compared to controls (Murueta-Goyena et al., 2021), but it is
present from prodromal stages (Lee et al., 2019a,b), suggesting
that an early but active neurodegeneration takes place in PD
retina (Murueta-Goyena et al., 2021).
Previous publications have indicated that, in addition to
neurodegeneration, the vascular component might be a key
contributing factor to the pathogenesis and progression of PD
(Bradaric et al., 2012; Guan et al., 2013; Yang et al., 2015).
In fact, brain autopsies of PD patients have revealed capillary
disruption (Guan et al., 2013), angiogenesis (Bradaric et al.,
2012), and small vessel degeneration in substantia nigra, middle
frontal cortex and brainstem nuclei (Yang et al., 2015). It
has been suggested that retinal vasculature shows similarities
with cerebral microcirculation and can be therefore used as a
surrogate marker of cerebral microvascular pathology (Patton
et al., 2005). Within the retina, blood flow to inner retinal
layers comes from capillaries derived from the central retinal
artery, whereas outer retinal layers are supplied by choroidal
vasculature. Recent advances in OCT technology allow the
visualization of retinal vasculature using non-invasive, depth-
selective, and high-resolution images. OCT angiography (OCT-
A) detects blood flow down to the capillary level by measuring
changes in OCT signal in consecutive cross-sectional images
taken at the same location and allows a three-dimensional
mapping of retinal microvasculature. Studying the morphometric
variations of capillary networks in PD might provide key
information about the regional neuronal structure, and the
basis for investigating retinal vascular morphological features
as potential biomarkers of cerebral microcirculation in PD.
Although to date few studies have explored retinal vascular
alterations in PD using OCT-A, the observations so far support
the view that retinal vascular alterations are present in PD
(Kromer et al., 2016; Kwapong et al., 2018; Rascunà et al.,
2020; Shi et al., 2020; Zou et al., 2020; Robbins et al.,
2021).
On the other hand, the relationship between cerebral small
vessel disease and cognitive decline is well-established (Zanon
Zotin et al., 2021). In PD, cognitive impairment is present in
15 to 40% of patients at diagnosis or early stages of the disease
(Aarsland et al., 2009; Pfeiffer et al., 2014), and about 80% of
PD patients will progress to dementia, but the rate of disease
progression is not uniform across patients (Aarsland et al.,
2017). Recent evidence shows that subjects with mild cognitive
impairment (MCI) display retinal vascular network impairment
(Chua et al., 2020; Criscuolo et al., 2020; Shin et al., 2021).
Similarly, it seems that PD patients with GCIPL atrophy might
constitute a clinical endophenotype with more pronounced
cognitive impairment and worse prognosis (Murueta-Goyena
et al., 2019, 2021). However, the relationship between the
cognitive status, retinal microvascular parameters and retinal
layer thicknesses has not been fully explored in PD patients.
In this study, we aimed to extensively describe retinal vascular
morphometric parameters in PD patients using high-resolution
Spectralis OCT-A images, in order to verify the presence of
microvascular abnormalities in PD compared to controls or
specific alterations in PD-MCI compared to PD patients with
normal cognition. We also evaluated the association of retinal
microvascular parameters with retinal thickness measurements
and disease-related clinical variables. Finally, we assessed the
diagnostic accuracy of retinal microvascular parameters alone or
in combination with the thickness of retinal layers to differentiate
PD patients from controls.
MATERIALS AND METHODS
Design and Participants
55 patients with Parkinson’s disease (105 eyes) and 48 controls
(95 eyes) were initially recruited for the present cross-sectional
study from June 2020 to March 2021. We included individuals
aged 40 years or older. PD patients were recruited through the
outpatient neurology department at Cruces University Hospital
and fulfilled PD Parkinson’s UK Brain Bank criteria for the
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diagnosis of PD before enrollment. Demographic data, disease
onset, disease severity and type and dosage of dopaminergic
treatment were collected. One experienced neurologist in the
field of movement disorders recorded disease onset, Unified
Parkinson’s Disease Rating Scale (UPDRS) score, and calculated
Levodopa Equivalent Daily Dose (LEDD). All patients were
studied in an on-state of medication. Control individuals without
PD or a history or symptoms of other neurological conditions
were also enrolled in the study. Montreal Cognitive Assessment
(MoCA) was administered to all participants to evaluate general
cognition. A cutoff of 24 was established for determining MCI in
this Spanish population (Milani et al., 2018).
All participants completed a comprehensive questionnaire
on current comorbidities to check for the following systemic
exclusion criteria: severe smoking (>20 cigarettes/day), heavy
alcohol use (>4 drinks/day for men or >3 drinks/day for
women), diagnosis of any type or grade of diabetes, uncontrolled
or resistant elevated blood pressure, history of consumption
of drugs or medications known to induce retinal toxicity or
cognitive impairment, chronic inflammatory systemic diseases
(e.g., lupus erythematosus, sarcoid, Bechet disease), history
of brain trauma or central nervous system diseases different
from PD. Participants with well-controlled hypertension without
complications were included in the study.
PD patients and controls underwent a complete
ophthalmologic examination including pupillary reflexes,
refraction, visual acuity, color discrimination, slit lamp
examination, and spectral domain OCT. Spherical equivalent
refractive error above 4.00 diopters or more than 3.00 diopters
of astigmatism or any ocular or systemic pathological condition,
except PD, influencing retinal OCT measures were considered
exclusion criteria. OCT-A images with visually identifiable
motion artifacts or incomplete acquisitions were excluded
from the analyses.
The study protocol was approved by the regional Basque
Clinical Research Ethics Committee. All participants gave written
informed consent prior to their participation in the study, in
accordance with the tenets of the Declaration of Helsinki.
Spectral Domain Optical Coherence
Tomography (OCT)
Macular retinal thickness was assessed using the Spectralis
spectral-domain OCT system (HRA2 Acquisition Module
version 6.16.6.0, Heidelberg Engineering, Heidelberg, Germany).
Macular volumetric scans consisted of 25 single horizontal axial
scans (B-scans) covering a 20◦ × 20◦ area, with 512 A-scans per
B-scan and 49 frames averaged per B-scan. Layer segmentation
of the OCT data was performed with the built-in software.
All OCT images fulfilled quality control criteria from OSCAR-
IB consensus (Tewarie et al., 2012), accounting for Obvious
problems (O), poor Signal strength (S), Centration of scan (C),
Algorithm failure (A), Retinal pathology other than PD-related
(R), Illumination (I), and Beam placement (B).
Macular volumetric scans were exported in raw format (∗.vol)
and imported into MATLAB 2018b and 2019b (Mathworks,
Natick, MA, United States) using the openVolFast.m function
of the AURA tools software (Lang et al., 2013). The central
point of the macula was determined as the point of minimum
thickness after smoothing the thickness map with a circular
kernel of 0.05 mm radius (foveaFinder.m function of AURA
tools). The thickness values derived from the acquired raster
pattern were resampled to a regular grid using cubic interpolation
and 0.02 mm spacing between adjacent points. Then, the average
thickness within the foveal zone (central 1-mm diameter disc)
and parafoveal area (2.5-mm diameter ring adjacent to the
foveal zone) were computed by averaging the point-by-point
thicknesses in each sector.
The foveal and parafoveal thicknesses were calculated
for the following layer complexes: total retinal thickness
(Retina), macular nerve fiber layer (mRNFL), ganglion cell-
inner plexiform complex (GCIPL), inner nuclear layer (INL),
outer plexiform-Henle fiber-outer nuclear layer (OPL-ONL),
and the complex including external limiting membrane
and photoreceptor inner and outer segments (ELM-IS/OS)
(Figure 1).
Spectral Domain Optical Coherence
Tomography Angiography (OCT-A)
High-resolution acquisition was performed with Spectralis OCT
Angiography Module (Heidelberg Engineering, Germany) which
offers a lateral resolution of 5.7 µm and an axial resolution
of 3.9 µm per pixel, using a scanning area of 10◦ × 10◦ and
512 A-scans per B-scan. TruTrack Active Eye Tracking was
used to avoid motion artifacts. Superficial and deep vascular
plexus complexes of the macula were investigated [superficial
vascular complex (SVC) located between the ganglion cell layer
and the inner mid-part of inner plexiform layer and deep
vascular complex (DVC) located between the outer mid-part
of inner plexiform layer and outer plexiform layer]. En face
images were exported from Spectralis and stored as 768 × 768
pixels jpeg images.
OCT-A Image Processing
MATLAB 2018b and 2019b and Python (v3.8.5) were used to
develop image analysis and parameter extraction algorithms. For
vascular and foveal feature extraction, en face OCT-A images
were first cropped to remove the SLO funduscopic image of the
periphery. Then, OCT-A images were scaled using X and Y axis
scaling parameters from Spectralis OCT-A to obtain images of
1:1 pixel:µm correspondence. We defined the foveal zone as the
central 1-mm disc, and the parafovea as the ring surrounding the
foveal zone, with an outer diameter of 2.5 mm. The center of the
inner 1-mm diameter circle and outer 2.5 mm diameter ring was
the centroid of the FAZ in DVC, i.e., the same center location was
used in SVC and DVC for calculating microvascular parameters
in different concentric regions (Figure 1).
For microvascular parameter extraction, OCT-A images were
first enhanced using median filtering and later processed with
a top-hat filter to improve the contrast in the image. The
images were binarized using adaptive thresholding. In SVC, a
separate binarization algorithm was applied based on Otsu’s
threshold to segment large blood vessels. By subtracting large
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FIGURE 1 | OCT-A image processing pipeline and evaluated retinal layers and regions for OCT and OCT-A images. The analysis protocol of the OCT-A images
(A) was different for the superficial vascular complex (SVC) and for the deep vascular complex (DVC) (see “Materials and Methods” for more details). Both SVC and
DVC images were cropped & rescaled (1) and binarized with an adaptive threshold (“adapt. thld.”) (2). In SVC images, after being binarized, the large vessels were
segmented (3) and the microvessels were binarized (4). With binarized SVC microvessel and binarized DVC images, images for vessel skeleton (5) and perimeters (6)
were obtained. From the vessel skeleton images, the “skeleton density” was quantified, from vessel perimeter images the “vessel perimeter index” was computed
and from the combination of vessel skeleton and perimeter images, the “mean diameter of blood vessels” was computed. From the binarized images of SVC and
DVC, the parameters “Lacunarity,” “Perfusion density,” and “Fractal dimension” were calculated. Finally, the cropped & rescaled DVC images were pre-processed
with white top-hat and opening/closing to segment the foveal avascular zone (FAZ) mask, from which “FAZ area” and “FAZ circularity” were computed. The layers of
the retina that were segmented from the OCT images (B) were macular retinal nerve fiber layer (mRNFL), ganglion cell-inner plexiform layer complex (GCIPL), inner
nuclear layer (INL), outer plexiform layer, Henle fibers, and outernuclear layer complex (OPL-ONL) and the complex including external limiting membrane and internal
andouter segments of photoreceptors (ELM-IS/OS). The mean thickness of the mentioned layers was obtained for two macular regions (B,C): the foveal region
(central circle of 1 mm in diameter) and the parafoveal ring (centered in the fovea and delimited by circles with an inner diameter of 1-mm and outer diameter of
2.5 mm). For both regions, the mean thicknesses of the mentioned retinal layers and the described OCT-A parameters were calculated.
vessel segmentation to the binarized OCT-A images, we obtained
SVC microvasculature. As the OCT-A detects blood flow down
to the capillary level by measuring the changes in OCT signal in
consecutive cross-sectional images, the whiteness of the binarized
images reflects the probability of perfusion. This allowed us to
calculate microvascular perfusion density as the ratio between
the number of white pixels of the binarized image and the total
number of pixels in the region of interest. The binarized images
of the microvasculature were further processed to extract the
skeleton of the vasculature using a built-in function in MATLAB.
Furthermore, a Canny edge detector was implemented to detect
the borders of the vasculature. From these images, we computed
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the following microvascular parameters: skeleton density as the
number of pixels of the skeleton divided by the number of pixels
in the region, the vessel perimeter index (Alam et al., 2017), mean
vessel diameter (Alam et al., 2017), the fractal dimension (FD)
estimated with Hausdorff (Box-counting) method (Harrar and
Hamami, 2007) and lacunarity with gliding box method (Tolle
et al., 2008). The lacunarity parameter used herein refers to the
calculation of lacunarity using a box-size of 512 pixels, which
represents a relative box-size of 0.1741 with respect to the rescaled
binarized image. These parameters were extracted in the foveal
zone and the parafovea. FD, lacunarity and perfusion density
were dimensionless, skeleton density and vessel perimeter index
were measured in 1/mm (length per unit of area) and mean vessel
diameter in µm.
For foveal avascular zone (FAZ) parameter extraction, FAZ
was first segmented using a parameterized version of Díaz et al.
(2019). The process consisted of a top hat transform for image
enhancement, Canny edge detection processing (including a
Gaussian filter), and the application of opening and closing
morphological operations to remove noise and fill holes. The FAZ
area (mm2) was measured, and the circularity was calculated with
the following formula: 4π (area/perimeter2).
Statistical Analysis
Statistical analysis was done in R (version 3.6.1) and RStudio
(version 1.2.1335). Group differences of demographic categorical
variables were tested using Chi square test. Quantitative variables
were described using mean and standard deviation. Normality of
data was visually inspected and tested with Shapiro-Wilks. Group
comparisons of normally distributed variables were done with
T-test and non-normally distributed data assessed with Mann
Whitney U-test. The analyses of OCT and OCT-A parameters
were conducted using generalized estimating equation (GEE)
models with an exchangeable working correlation structure to
account for correlation between the two eyes from a single
participant. Effect sizes were calculated with Cohen’s d. To test the
diagnostic ability of OCT-A parameters alone or in combination
with demographic or retinal thickness variables, we fitted logistic
GEE models and their predictive ability was tested in ROC
curves, using fitted values as predictors. For this, we first fitted
the null model including age, sex, and hypertension as a priori
confounders, and then added retinal variables for the full model.
The differences in goodness-of-fit between models were tested
with Wald test. All GEE analyses were performed with geepack
package and ROC curves calculated with pROC package. p-values
lower than 0.05 were considered statistically significant.
RESULTS
A total of 87 eyes from 49 PD patients and 73 eyes from 40
controls were analyzed after removing the acquisitions with
visually identifiable motion artifacts, incomplete acquisitions or
eyes presenting ocular exclusion criteria.
The demographics and clinical characteristics of participants
are listed in Table 1. There were no statistically significant
differences in age, but the proportion of females was larger in
the control group. The mean disease duration was 7.1 ± 4.1
years (range 0.4 to 19.4 years), and the mean UPDRS motor
score was 27.7 ± 7.7 (range, 9 to 54). The cognitive status was
similar between PD and controls, but the proportion of subjects
with MCI was larger in PD group. In PD patients, MoCA score
presented a mild correlation with motor deficits (r = −0.292,
p = 0.04). The frequency of well-controlled hypertension was
comparable in both groups.
PD patients were further divided into two groups: PD patients
with MCI (PD-MCI) (n = 18) and PD patients with normal
cognition (PD-NC) (n = 31). The mean age of PD-MCI was
67.1± 8.9 years and in PD-NC it was 63.1± 6.9 years (p= 0.11).
Disease duration was comparable among both groups (PD-MCI
6.3 ± 4.4 vs. PD-NC 7.5 ± 4.0, p = 0.3). The proportion of
females was also similar in both groups (PD-MCI 38.9% and PD-
NC 32.2%, p = 0.9), as well as the proportion of patients with
well-controlled hypertension (PD-MCI 16.6% and PD-NC 22.2%,
p= 0.7).
Comparison of Microvascular
Parameters Between PD Patients and
Controls
Comparing PD patients and controls, significant differences were
found in FAZ area in SVC (p = 0.004) and DVC (p < 0.001)
with a medium to large effect size, but not in FAZ circularity.
After controlling for a priori confounders (i.e., age, sex, and
hypertension), FAZ area remained significantly smaller in PD
patients compared to controls in both SVC and DVC (estimate
−0.1 µm, adjusted p = 0.004 in SVC and p = 0.014 in
DVC) (Table 2).
When analyzing differences in microvascular parameters
between PD patients and controls, skeleton density, perfusion
density and vessel perimeter of PD patients were increased in
the foveal zone, with statistically significant differences compared
TABLE 1 | Demographics and clinical characteristics of participants.
PD Control p-value
n 49 40
Age (years) 64.6 (7.9) 62.1 (8.0) 0.2
Sex (female n, %) 16 (34.7%) 27 (67.5%) <0.001
MoCA 24.4 (4.1) 25.7 (2.5) 0.3
MCI (n, %) 18 (36.7%) 6 (15%) 0.03
Hypertension (n, %) 12 (24.5%) 7 (17.5%) 0.59
Disease Duration (years) 7.1 (4.1) –
UPDRS I 2.0 (1.5) –
UPDRS II 10.8 (4.0) –
UPDRS III 27.7 (7.7) –
UPDRS IV 4.0 (2.9) –
LEDD (mg) 647.5 (364.6) –
Categorical data are expressed as number and percentage, whereas quantitative
data is expressed as mean (standard deviation). The proportion of participants with
well-controlled or benign hypertension is provided for each group. LEDD, Levodopa
Equivalent Daily Dose; MCI, Mild Cognitive Impairment; MoCA, Montreal Cognitive
Assessment; n, sample size; PD, Parkinson’s disease; UPDRS, Unified Parkinson’s
disease Rating Scale.
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to controls (Figure 2). Moreover, PD eyes showed increased FD
and lacunarity of both complexes in the foveal zone. Adjusted
GEE models showed that the SVC lacunarity and FD, and
DVC lacunarity, skeleton density and perfusion density were
significantly different between groups (Table 2), being the effect
size particularly large for lacunarity. On the other hand, the
parafoveal lacunarity in the retina of PD patients was significantly
decreased in SVC and significantly increased in DVC (GEE,
p < 0.001), but no differences were observed in the remaining
parafoveal microvascular parameters.
Retinal Thicknesses and Its Association
With Microvascular Parameters
Multivariate GEE adjusted for age, sex and hypertension showed
no significant differences in retinal thickness or its layers between
PD patients and controls.
In the foveal zone, FAZ area was negatively associated with
GCIPL and INL thickness in both PD patients and controls
(p < 0.001), and no significant associations were found with
ELM-IS/OS thickness in any group. These results suggest that
the foveal microvasculature significantly contributes to OCT
thickness measurement of inner retinal layers in normal and
pathological conditions. In a similar fashion, in both groups,
skeleton density, perfusion density, FD, and vessel perimeter of
both plexuses were positively associated with the thickness of
inner retinal layers (GCIPL and INL), but not with ELM-IS/OS.
However, a unique positive association was found in PD
patients between microvascular parameters and OPL-ONL in the
fovea. Concretely, FAZ areas in SVC and DVC were negatively
associated, and skeleton density, perfusion density, and vessel
perimeter of both plexuses were positively associated with OPL-
ONL thickness, indicating that increased capillary bed in the
fovea was related to OPL-ONL thickening. Also, foveal lacunarity
of DVC was associated with GCIPL, INL and OPL-ONL thinning
in PD patients, but not in controls.
In the parafovea of PD patients, a positive association was
found between some microvascular parameters of the SVC,
including skeleton density, perfusion density, FD and vessel
perimeter with parafoveal GCIPL thickness (GEE, adjusted
p-values: 0.014, 0.006, <0.001, and 0.013, respectively), but not
with the thickness of the remaining retinal layer complexes. No
such significant associations were found in control participants.
None of the microvascular parameters of DVC were associated
with retinal thicknesses in the parafovea.
Retinal Parameters in PD Patients With
Mild Cognitive Impairment
We also tested whether differences in microvascular parameters
could be detected between PD patients with and without MCI.
Some of such parameters tended to be lower in PD-MCI
compared to PD-NC patients, like DVC lacunarity in the foveal
zone or SVC skeleton density in the parafovea, but the differences
did not reach statistical significance (Table 3). FAZ area was
larger and FAZ circularity was decreased in PD-MCI patients, and
both parameters were significantly different in SVC compared
to PD-NC patients.
On the other hand, we observed that in PD-MCI retinal
thickness was 6 µm lower in the parafovea and 9 µm lower
in the foveal zone compared to PD-NC patients. Most of the
parafoveal retinal thickness decrease in PD-MCI was accounted
for changes in GCIPL (absolute difference of 4 µm). Contrarily,
in the foveal zone, the GCIPL only accounted for a third part of
the total retinal thinning (3 µm thinner), whereas foveal OPL-
ONL thickness accounted for the rest (6 µm lower in PD-MCI
vs. PD-NC, GEE, p = 0.047). However, none of these differences
TABLE 2 | Foveal microvascular changes in PD.
PD Control Cohen’s d Univariatep-value Multivariate p-value
FAZ area (mm2) SVC 0.669 ± 0.214 0.824 ± 0.292 0.61 0.004 0.004
DVC 0.401 ± 0.181 0.544 ± 0.198 0.75 <0.001 0.014
FAZ circularity SVC 0.187 ± 0.038 0.194 ± 0.029 0.21 0.280 0.686
DVC 0.257 ± 0.045 0.271 ± 0.043 0.32 0.067 0.210
Lacunarity SVC 6.0 ± 0.4 5.7 ± 0.4 0.75 <0.001 <0.001
DVC 12.8 ± 0.7 9.8 ± 3.2 1.30 <0.001 <0.001
Fractal Dimension SVC 1.42 ± 0.05 1.37 ± 0.09 0.69 0.008 0.027
DVC 1.49 ± 0.04 1.47 ± 0.04 0.50 0.030 0.127
Perfusion Density SVC 0.14 ± 0.04 0.11 ± 0.05 0.66 0.009 0.112
DVC 0.22 ± 0.04 0.20 ± 0.05 0.44 0.020 <0.001
Skeleton Density (1/mm) SVC 6.0 ± 1.9 4.8 ± 2.2 0.58 0.052 0.650
DVC 8.6 ± 1.9 7.6 ± 1.8 0.54 0.034 0.002
Vessel Perimeter Index (1/mm) SVC 17.1 ± 4.8 13.6 ± 5.6 0.67 0.006 0.210
DVC 27.6 ± 5.2 23.6 ± 5.6 0.74 0.003 0.541
Vessel Diameter (µm) SVC 23.3 ± 1.6 23.7 ± 2.1 0.21 0.160 0.056
DVC 26.1 ± 2.1 25.8 ± 2.0 0.15 0.320 0.944
Microvascular parameters are expressed as mean± standard deviation for each group. Cohen’s d represents the effect size. p-values were obtained with GEE. Multivariate
p-values are adjusted for age, sex, and hypertension. Significant results are highlighted in bold. Microvascular parameters without units are dimensionless. DVC, deep
vascular complex; FAZ, foveal avascular zone; PD, Parkinson’s disease; SVC, superficial vascular complex.
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FIGURE 2 | Representative images of the microvascularization in the foveal zone in controls and PD patients. Top panel figures show binarized images of the Deep
Vascular Complex of the retina, centered in the centroid of the Foveal Avascular Zone (FAZ), in a circle with a radius of 500 µm. The scaling factor was 5.60 in both
subjects, so the differences in FAZ size cannot be attributed to ocular biometric differences or magnification effects. Graphs correspond to the results in the Deep
Vascular Complex. Significance levels of unadjusted GEE models are represented with an asterisk: *p < 0.05, ** p < 0.01, *** p < 0.001.
reached statistical significance after controlling for the effect of
age, sex, and hypertension (Table 3).
Interestingly, we observed that parafoveal GCIPL thickness
was significantly associated with parafoveal microvascular
parameters in SVC, including skeleton density, perfusion density,
fractal dimension, lacunarity and vessel perimeter, but only in
PD-MCI and not in PD-NC.
Association Between Microvascular
Parameters and Clinical Outcomes
In PD patients, FAZ area and circularity of SVC were significantly
associated with MoCA scores (GEE, p = 0.028, p = 0.036,
respectively), but not with disease duration or UPDRS III scores.
However, the relationship between superficial FAZ parameters
and cognitive function lost significance when controlling for the
effect of covariates. None of the remaining foveal or parafoveal
microvascular parameters yielded significant associations with
disease duration, motor impairment or cognitive outcomes.
Diagnostic Accuracy of Macular
Parameters
To test the diagnostic ability of OCT-A parameters alone or
in combination with demographic, clinical, or retinal thickness
variables, we fitted multivariable logistic GEE models and their
predictive ability was tested in ROC curves. We first fitted
the null model including age, sex, and hypertension as the
a priori confounders. This yielded an area under the curve
(AUC) of 0.691 (95% CI, 0.601 – 0.772). Then, we included
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FAZ area (mm2) SVC 0.73 ± 0.20 0.63 ± 0.21 0.49 0.049
DVC 0.43 ± 0.17 0.38 ± 0.18 0.29 –
FAZ circularity SVC 0.17 ± 0.02 0.20 ± 0.04 0.95 0.001




Fractal Dimension SVC 1.40 ± 0.05 1.42 ± 0.05 0.40 –
DVC 1.49 ± 0.04 1.50 ± 0.04 0.25 –
Lacunarity SVC 6.02 ± 0.32 6.03 ± 0.48 0.02 –
DVC 12.59 ± 0.63 12.91 ± 0.66 0.50 –
Skeleton Density
(1/mm)
SVC 11.8 ± 1.5 11.7 ± 1.2 0.07 –
DVC 12.0 ± 1.2 12.1 ± 1.3 0.08 –
Perfusion Density SVC 0.28 ± 0.04 0.27 ± 0.03 0.28 –
DVC 0.31 ± 0.02 0.32 ± 0.02 0.50 –
Parafovea
Fractal Dimension SVC 1.63 ± 0.02 1.63 ± 0.01 0 –
DVC 1.69 ± 0.01 1.69 ± 0.01 0 –
Lacunarity SVC 1.04 ± 0.01 1.04 ± 0.01 0 –
DVC 10.98 ± 0.24 11.14 ± 0.24 0.67 –
Skeleton Density
(1/mm)
SVC 11.4 ± 1.4 11.8 ± 1.3 0.30 –
DVC 13.4 ± 1.2 13.5 ± 1.2 0.08 –
Perfusion Density SVC 0.24 ± 0.02 0.24 ± 0.02 0.00 –
DVC 0.35 ± 0.01 0.35 ± 0.01 0.00 –
Thickness (µm)
Fovea
Retina 277.1 ± 19.1 286.3 ± 18.2 0.49 0.045
GCIPL 36.0 ± 7.7 39.4 ± 7.9 0.44 –
INL 19.4 ± 6.1 21.0 ± 5.9 0.27 –
OPL-ONL 117.2 ± 13.7 123.3 ± 8.4 0.54 0.047
ELM-IS/OS 49.6 ± 6.2 49.1 ± 4.9 0.09 –
Parafovea
Retina 339.4 ± 14.8 345.9 ± 13.3 0.46 –
GCIPL 92.0 ± 8.5 96.3 ± 7.2 0.55 0.039
INL 40.7 ± 2.8 40.7 ± 4.3 0 –
OPL-ONL 104.7 ± 8.1 106.1 ± 6.6 0.19 –
ELM-IS/OS 44.2 ± 3.5 44.0 ± 3.0 0.06 –
Data are expressed as mean ± standard deviation for each group. Cohen’s d
represents the effect size. p-values were obtained with univariate GEE. P-values
are only provided for significant results. DVC, deep vascular complex; ELM-
IS/OS, macular complex including external limiting membrane and inner and outer
segments of photoreceptors; FAZ, foveal avascular zone; GCIPL, ganglion cell-
inner plexiform complex; INL, inner nuclear layer; OPL-ONL, complex including
the outer plexiform and outer nuclear layers; PD-MCI, Patients with Parkinson’s
disease and Mild Cognitive Impairment; PD-NC, patients with Parkinson’s disease
and normal cognition; SVC, superficial vascular complex.
single microvascular parameters that differed most between
PD patients and controls, including FAZ area, foveal skeleton
density, perfusion density and lacunarity (both plexuses), foveal
FD in SVC and parafoveal lacunarity (both plexuses). Each
model was then compared to the null with Wald test to test
whether microvascular parameters significantly contributed to
diagnostic accuracy. From this, we observed that 3 parameters
significantly contributed to the model, providing excellent
diagnostic accuracies (AUC > 0.8). These parameters were the
lacunarity in DVC fovea (AUC = 0.852, 95% CI 0.79 – 0.92),
lacunarity in DVC parafovea (AUC = 0.838, 95% CI 0.77 –
0.90) and lacunarity in SVC parafovea (AUC = 0.835, 95%
CI 0.77 – 0.90) (Figure 3). Further adding retinal thicknesses
of the parafovea or central macula or combining different
microvascular parameters did not significantly improve the
classification performance.
DISCUSSION
In the present study, we observed retinal capillary alterations
in the central macula of PD patients. The area of the FAZ in
both superficial and deep vascular plexuses was significantly
smaller in PD patients compared to controls. In line with this
finding, the perfusion and density of capillaries in the foveal
zone was greater in PD patients, mainly in deep vascular plexus,
suggesting an enlarged vascular bed surrounding FAZ. Moreover,
fractal dimension and lacunarity of capillaries were greater in
this region reflecting the increased vascular complexity and
heterogeneity in PD fovea. Remodeling of foveal capillary bed was
associated with increased OPL-ONL thickness in PD patients.
Even though we failed to find differences in microvascular density
or perfusion in the parafovea, parafoveal lacunarity significantly
differed between patients and controls. Interestingly, parafoveal
microvascular parameters on the superficial vascular complex
were associated with GCIPL thickness in PD patients, but not in
controls, and these associations were mainly driven by PD-MCI.
Our results demonstrate that retinal microvascular alterations in
PD are mainly restricted to the fovea, and that the parafoveal
GCIPL atrophy in PD-MCI is associated with the superficial
vascular supply.
Previous studies have explored retinal vascular alterations in
PD. The first study analyzing retinal vascular changes in PD was
conducted using fluorescein angiography (FA) (Miri et al., 2015).
Although the resolution for fine capillary vessels of retinal FA
is somewhat limited, these authors found a shrinking of FAZ
in PD patients compared to controls, which is in line with the
results of the current study using OCT-A images and improved
algorithms to enhance the visualization of capillaries around the
FAZ. Furthermore, we found that the decrease in FAZ area was
accompanied by an increase in microvascular parameters in the
foveal zone, like skeleton and perfusion density, fractal dimension
or lacunarity. This contrasts with the results of Zou et al. who
found less vessel length and perfusion in the central macula of
PD patients and no changes in FAZ area (Zou et al., 2020), and
with the results of Rascunà et al. who did not find vascular density
changes in the foveal zone of early PD patients (Rascunà et al.,
2020). Some of these differences might be attributed to smaller
sample sizes, differences in disease stage of patients and study
design flaws of previous studies.
The first study using OCT-A in PD was published in 2018,
where Kwapong et al. (2018) nicely described a decrease in
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FIGURE 3 | Receiver operating characteristic (ROC) curves for testing the diagnostic accuracy of microvascular parameters. Fitted values resulting from logistic
regression were used as classifiers. ROC curve for the null model is shown in red, in which confounding demographical and clinical variables were used as
independent factors, including age, sex, and hypertension. In blue, ROC curves of regression models that were significantly different from null (Wald test) after adding
single microvascular parameters to the model. AUC, area under the curve; DVC, deep vascular complex; SVC, superficial vascular complex.
parafoveal microvascular density of superficial vascular complex
in PD and its relationship with GCIPL thickness decrease. Similar
results were reported by Shi et al. (2020). Nonetheless, none of
these authors explored microvascular alterations in the foveal
zone, where the fundamental microvascular alterations occur
according to the present study. They did neither control for the
inter-eye correlation in statistical analyses, possibly increasing
the rate of false positive findings in the parafovea. In our
study, we used GEE models to control for this effect, and
did not find significant changes in the parafoveal skeleton or
perfusion density. Nonetheless, part of their results coincides
with ours, as we also found an association between the
parafoveal microvascular density and GCIPL thickness, even after
adjusting for confounding variables. Similarly, Rascunà et al.
(2020), did not observe significant differences in the parafoveal
microvascular density between early PD patients and controls
but did find a correlation of inner retinal layer thickness and
microvascular density. However, these correlations were mostly
restricted to the foveal zone, and in the present study, we
showed that such associations were not specific to PD, as they
were also observed in controls. More recently, Robbins et al.
(2021) used larger sample sizes, including 124 eyes of 69 PD
patients and 248 eyes of 137 controls, concluding that retinal
superficial capillary vessel density and perfusion density around
the foveal zone are decreased in PD compared to age and
sex-matched control participants, but no correlation analyses
with retinal thickness were performed. Intriguingly, we observed
that the association between parafoveal GCIPL thickness and
microvascular parameters in PD was mainly driven by PD-
MCI patients, whose parafoveal GCIPL was significantly reduced
compared to PD-NC patients. As far as we know, this is the first
study that classifies PD patients into subgroups in an attempt
to unravel OCT-A differences between clinical endophenotypes.
Even though few significant differences were found, PD-MCI
tended to display larger FAZ areas and less FAZ circularity
than PD-NC. Future studies with larger sample sizes might
confirm this trend.
To date, few studies have assessed retinal vascular descriptors
beyond density that can be useful for increasing the information
obtainable from OCT-A images. Fractal dimension is a widely
known parameter for describing shape or texture, and determines
the complexity of an image. Two studies calculated FD of the
retinal vasculature of PD patients finding contradictory results.
Miri et al. (2015) did not find differences using FA, whereas Shi
et al. (2020) reported decreased FD in the parafoveal superficial
and deep vascular plexuses using OCT-A. This contrasts with our
results, as we did not find differences in FD in the parafoveal
region, but the FD within the foveal zone was significantly
increased in PD patients. On the other hand, lacunarity is
a feature descriptor that determines the heterogeneity of an
image and complements FD. Lacunarity expresses patchiness
or inhomogeneity of an image, and since it is not predicated
on fractality, it may be particularly useful for characterizing
the texture of retinal microvasculature. Indeed, in our study
lacunarity was the parameter that differed most between patients
and controls. The lacunarity within the foveal zone was
significantly higher in PD patients compared to controls, even
after adjusting for age, sex, and hypertension, suggesting that the
distribution of capillaries was more heterogeneous in this region,
with larger dispersion of gap sizes. The parafoveal lacunarity
was greater in DVC in both PD patients and controls, as
this plexus contains irregularly distributed vascular loops and
vascular branches extending from a central seed point, notably
increasing image heterogeneity (Hirano et al., 2018). Still, in the
present work this parameter was also found to be significantly
higher in PD patients compared to controls.
Moreover, lacunarity yielded the best diagnostic accuracy.
Many efforts are being devoted to the identification and
characterization of PD biomarkers. Notwithstanding the progress
made so far, reliable biomarkers are still lacking. In this work, we
showed that foveal lacunarity could be a promising biomarker
for differentiating patients from controls, as a significantly
greater AUC was achieved after adding this parameter to
the null model that controlled for confounding variables
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like age, sex, and hypertension. In a previous study of Zou
et al. (2020), similar AUCs were obtained after combining
OCT-A and OCT parameters. However, these authors only
accounted for capillary length and density, and no further
microvascular parameters were considered. In our study, the
combination of microvascular and structural modifications did
not increase the classification accuracy, and lacunarity could
be considered as a single imaging biomarker for discriminating
patients from controls. The differences in microvascular
imaging parameters between PD patients and controls, and
the lack of association between these parameters with disease
duration or severity, further support OCT-A as a useful
diagnostic marker.
An important aspect to consider for the comparability of
OCT-A studies is the critical contribution of technical differences
among OCT-A devices. The definition of the delimiting
boundaries of retinal vascular plexuses determines the tissue and
associated vasculature that is represented in two-dimensional en
face images. It is known that the location of these boundaries
varies among OCT-A devices and limits the comparability of
OCT-A studies (Li et al., 2018). So far, 2 OCT-A devices have been
used to explore the vascular changes in PD, namely, AngioVue
XR Avanti (Optovue Inc, Fremont, California, United States)
and AngioPlexTM OCTA system (Cirrus; Zeiss, Dublin). In
both devices, the intermediate capillary plexus (ICP) defined by
Campbell et al. (2017) is considered to be part of SVC, whereas
in Spectralis OCT-A the ICP pertains to DVC. Also, the axial
resolution is similar among the 3 OCT-A devices (5 µm), but the
lateral resolution of the OCT beam of Spectralis is much higher
(5.7 µm) than the other two (15 µm). This is especially important
considering that the average diameter of small capillaries is about
8 µm (Tan et al., 2012). Therefore, Spectralis OCT-A enables a
more precise detection and more confident evaluation of vascular
abnormalities at capillary level. As far as we know, this is the first
study using Spectralis OCT-A in PD, and the mere use of this
device could account for some of the contradictory results of our
work compared to previous literature in PD.
The pathophysiological mechanisms driving retinal
microvascular changes in PD are still unknown. In autopsy
brains of PD patients, increased angiogenesis has been observed
(Bradaric et al., 2012) with abnormally fragmented capillaries
(Guan et al., 2013), increased expression of vascular endothelial
growth (VEGF) receptors (Wada et al., 2006), and the formation
of string vessels (Yang et al., 2015), supporting vascular events as a
contributing factor to the PD pathophysiology. Concretely, string
vessels are remnants of capillary vessels with no function in blood
flow, and are triggered by factors that promote angiogenesis,
like VEGF (Brown, 2010). As retinal and brain microvasculature
share similarities, string vessel formation in the foveal zone
could account for the current results. This hypothesis is partially
supported by a recent in-vitro study that has demonstrated
how degenerating retinal ganglion cells release VEGF to drive
their own survival (Froger et al., 2020). Moreover, we observed
that the relationship between microvascular parameters and
OPL-ONL thickness in the fovea was exclusively present in PD
patients, even though no significant thickness changes were
detected between PD patients and controls in this area. It might
be that the activation of VEGF receptor could not only promote
pro-angiogenic effects, but also a microinflammation of the
outer layers (Uemura et al., 2021). However, the mechanistic
basis of microvascular retinal changes cannot be inferred from
clinical studies.
Furthermore, the axons of retinal ganglion cells exit the eye
to form the optic nerve, optic chiasm, and optic tract, which in
turn synapse with other neurons in the lateral geniculate nucleus
that extend through the optic radiations to the occipital lobe.
Previous studies have observed morphometric abnormalities
of the intracranial visual pathway structures in drug-naïve
early PD patients, including decreased volume of chiasmatic
area, and reduced white matter concentration and diffusivity
in optic radiations (Arrigo et al., 2017). In future studies, it
would be interesting to acknowledge not only whether the
retinal microvascular alterations are associated to intracranial
morphometric and functional changes, but also related to
extracranial pathology, like pathology of carotid arteries.
Lastly, it is worth mentioning that the involvement of the
eye in PD goes beyond the retina. In the last years, it has been
demonstrated that PD patients show profound alterations of
corneal innervation with decreased density of corneal subbasal
nerve fibers and branches, and increased number of beadings
(Arrigo et al., 2018; Ulusoy and Ulusoy, 2020). Probably, this
denervation is responsible for the defective lacrimal reflex, and
the subsequent dry eye signs and symptoms that are commonly
reported in the literature (Biousse et al., 2004; Ekker et al., 2017).
One limitation of the current study was that the automatic
segmentation of vascular plexuses near the fovea might not
be completely accurate, as at this region the vascular plexuses
converge into a single plexus around the FAZ, and DVC might be
added to SVC in the fovea (Spaide and Curcio, 2017). However,
we observed that microvascular changes in both plexuses were
in line, but quantitative measurements should be interpreted
with caution. Moreover, to find a tradeoff between the speed
of acquisition and the resolution, the size of the field of view
from the current OCT-A system was smaller than in previous
studies. Nonetheless, we expected that macular changes in PD
were predominantly restricted to the most central areas. Also, the
cutoff for MCI was defined using MoCA scores, but future studies
should rely on a comprehensive set of neuropsychological tests
to refine the classification of PD patients. Several microvascular
parameters were compared between PD patients and controls,
and p-values were not corrected for multiple comparisons due
to the exploratory nature of these analyses, and this remains
a limitation of the current study. Finally, we did not account
for all the potential confounding variables, such as smoking,
intraocular pressure or axial length, although the effects of the
latter were mitigated by scaling the OCT-A images. Future studies
will benefit from using larger sample sizes to control for the effect
of these factors in multivariable regression analyses.
In conclusion, the identification of biomarkers for PD is
a mainstream in clinical research to forestall the progression
of PD. Early retinal abnormalities in PD could permit a fast,
non-invasive, and cost-effective imaging of surrogate markers.
Our results support retinal vascular alterations detectable by
OCT-A, mainly in the foveal zone, and as far as we know,
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our study is the first to describe changes in retinal vessel
lacunarity in PD as a potential diagnostic biomarker of PD.
Also, we indicate that PD patients with MCI might represent a
clinical subtype in which retinal small vessel disease is related
to retinal atrophy, although this working hypothesis needs to
be tested in future studies. It is important to acknowledge
the technical properties and limitations of each OCT-A device
to ensure optimal interpretation of the obtained results in
the clinical setting. The standardization of OCT-A vascular
plexuses segmentation, the extraction and analysis of common
vascular parameters and increasing the speed and resolution of
acquisitions will enable a more precise description of retinal
microvascular variations in PD. Without limiting the foregoing,
vascular alterations in PD might need to be corroborated in
postmortem retinas using histochemistry.
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